Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v4-EN
Language French English
Date Updated 2023-03-12 2023-02-08
Drug Identification Number 02423227 02423227
Brand name AMIODARONE HYDROCHLORIDE FOR INJECTION AMIODARONE HYDROCHLORIDE FOR INJECTION
Common or Proper name Amiodarone Hydrochloride Amiodarone Hydrochloride
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 3 mL vials 10 x 3 mL vials
ATC code C01BD C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Other (Please describe in comments) Demand increase for the drug.
Anticipated start date 2023-05-15
Actual start date 2023-02-06
Estimated end date 2023-06-15 2023-06-15
Actual end date 2023-03-07
Shortage status Avoided shortage Actual shortage
Tier 3 Status No No
Company comments Under allocation
Health Canada comments